Long-time Collaborators Botond Roska and José-Alain Sahel Win International Prize for Translational Neuroscience
22 juin 2023 03h00 HE
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Basel, Switzerland, June 22, 2023 --In recognition of their pioneering work on restoring vision to blind patients using optogenetic therapy, Botond Roska and José-Alain Sahel were today awarded the...
Arvinas to Participate in Upcoming Investor Conferences
05 juin 2023 07h00 HE
|
Arvinas Inc.
NEW HAVEN, Conn., June 05, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Catalyst Pharmaceuticals Reports Positive Momentum in Second Quarter 2023
01 juin 2023 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
Reaffirms Full Year 2023 Total Revenue Guidance of Between $375 Million and $385 Million Forecasts FIRDAPSE® 2023 Net Product Revenue Guidance of Between $245 Million and $255 Million, an...
Neuroscience Market to Surpass US$ 43.32 Billion by 2030, Says Coherent Market Insights (CMI)
19 mai 2023 09h31 HE
|
CMI
Burlingame, May 19, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global neuroscience market is estimated to be valued at US$ 32.75 billion in 2023 and is expected to exhibit a...
EMOTIV Enlists Two Machine Learning Heavyweights as AI Takes Aim at the Human Brain
01 mai 2023 09h00 HE
|
Emotiv Inc.
SAN FRANCISCO, May 01, 2023 (GLOBE NEWSWIRE) -- EMOTIV, the bioinformatics pioneer advancing understanding of the human brain using electroencephalography (EEG), today added two renowned scientists...
NeurologyLive® and CMSC Announce Giants of Multiple Sclerosis® 2023 Class of Inductees
26 avr. 2023 09h19 HE
|
NeurologyLive
CRANBURY, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- NeurologyLive® and the Consortium of Multiple Sclerosis Centers (CMSC) are pleased to announce the 2023 Giants of Multiple Sclerosis® inductees. ...
Novartis presents new five-year data on disability outcomes and safety of Kesimpta® (ofatumumab) in people living with relapsing multiple sclerosis
20 avr. 2023 01h15 HE
|
Novartis Pharma AG
The ALITHIOS open-label extension study showed continuous treatment with Kesimpta® (ofatumumab) for up to five years in relapsing multiple sclerosis (RMS) patients was associated with reduced risk of...
Magnetoencephalography Market to hit USD 534 Million by 2032, says Global Market Insights Inc.
18 avr. 2023 05h22 HE
|
Global Market Insights Inc.
Selbyville, Delaware, April 18, 2023 (GLOBE NEWSWIRE) -- Magnetoencephalography market value is estimated to exceed USD 534 million by 2032, according to a new research report by Global Market...
Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS
22 mars 2023 20h31 HE
|
Biogen Inc.
CAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced today the outcome of the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System...
Neuroscience of Stress and Metabolism - A Free Webinar from the Brain & Behavior Research Foundation
07 mars 2023 10h15 HE
|
Brain & Behavior Research Foundation
New York, March 07, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Neuroscience of Stress and Metabolism” on Tuesday, March 14, 2023, at...